Intraperitoneal infusion of mesenchymal stem/stromal cells prevents experimental autoimmune uveitis in mice

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Oh, Joo Youn ^a,b   Kim, Tae Wan ^c   Jeong, Hyun Jeong ^b   Lee, Hyun Ju ^b   Ryu, Jin Suk ^b   Wee, Won Ryang ^a,b   Heo, Jang Won ^a   Kim, Mee Kum ^a,b,d  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE UVEITIS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; LYMPH NODE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; RETINA INJURY; TH1 CELL; TH17 CELL; TUNEL ASSAY; ANIMAL; AUTOIMMUNE DISEASES; C57BL MOUSE; FLOW CYTOMETRY; INFUSION; PHYSIOLOGY; UVEITIS;

ANIMALS; AUTOIMMUNE DISEASES; FEMALE; FLOW CYTOMETRY; INFUSIONS, PARENTERAL; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; UVEITIS;

EID: 84921017903     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/624640     Document Type: Article

References (37)

1. D. C. Gritz and I. G. Wong, "Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study, " Ophthalmology, vol. 111, no. 3, pp. 491-500, 2004.
2. P. Lehoang, "The gold standard of noninfectious uveitis: corticosteroids, " Developments in Ophthalmology, vol. 51, pp. 7-28, 2012.
3. F. Willermain, J. T. Rosenbaum, B. Bodaghi et al. , "Interplay between innate and adaptive immunity in the development of non-infectious uveitis, " Progress in Retinal and Eye Research, vol. 31, no. 2, pp. 182-194, 2012.
4. R. R. Caspi, "A look at autoimmunity and inflammation in the eye, " Journal of Clinical Investigation, vol. 120, no. 9, pp. 3073-3083, 2010.
5. A. Uccelli and D. J. Prockop, "Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?" Current Opinion in Immunology, vol. 22, no. 6, pp. 768-774, 2010.
6. A. Uccelli, L. Moretta, and V. Pistoia, "Mesenchymal stem cells in health and disease, " Nature Reviews Immunology, vol. 8, no. 9, pp. 726-736, 2008.
7. K. English, A. French, and K. J. Wood, "Mesenchymal stromal cells: facilitators of successful transplantation?" Cell Stem Cell, vol. 7, no. 4, pp. 431-442, 2010.
8. A. Tyndall and A. Uccelli, "Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks, " BoneMarrow Transplantation, vol. 43, no. 11, pp. 821-828, 2009.
9. R. R. Caspi, "Experimental autoimmune uveoretinitis in the rat and mouse, " Current Protocols in Immunology, vol. 15, pp. 1-12, 2003.
10. A. OGarra, "Cytokines induce the development of functionally heterogeneous T helper cell subsets, " Immunity, vol. 8, no. 3, pp. 275-283, 1998.
11. E. Bettelli, Y. Carrier, W. Gao et al. , "Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, " Nature, vol. 441, no. 7090, pp. 235-238, 2006.
12. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger, "TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells, " Immunity, vol. 24, no. 2, pp. 179-189, 2006.
13. M. Rafei, P. M. Campeau, A. Aguilar-Mahecha et al. , "Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner, " Journal of Immunology, vol. 182, no. 10, pp. 5994-6002, 2009.
14. E. Svobodova, M. Krulova, A. Zajicova et al. , "Therole of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population, " Stem Cells and Development, vol. 21, no. 6, pp. 901-910, 2012.
15. X. Qu, X. Liu, K. Cheng, R. Yang, and R. C. H. Zhao, "Mesenchymal stem cells inhibit Th17 cell differentiation by IL-10 secretion, " Experimental Hematology, vol. 40, no. 9, pp. 761-770, 2012.
16. M. Ohshima, K. Yamahara, S. Ishikane et al. , "Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis, " Journal of Molecular and Cellular Cardiology, vol. 53, no. 3, pp. 420-428, 2012.
17. J. Xu, D. Wang, D. Liu et al. , "Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome, " Blood, vol. 120, no. 15, pp. 3142-3151, 2012.
18. S. Ghannam, J. Pene, G. Torcy-Moquet, C. Jorgensen, and H. Yssel, "Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype, " The Journal of Immunology, vol. 185, no. 1, pp. 302-312, 2010.
19. M. J. Park, H. S. Park, M. L. Cho et al. , "Transforming growth factor β-transducedmesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis, " Arthritis and Rheumatism, vol. 63, no. 6, pp. 1668-1680, 2011.
20. H. Ohtaki, J. H. Ylostalo, J. E. Foraker et al. , "Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14638-14643, 2008.
21. K. Nemeth, A. Leelahavanichkul, P. S. T. Yuen et al. , "Bone marrow stromal cells attenuate sepsis via prostaglandin E 2-dependent reprogramming of host macrophages to increase their interleukin-10 production, " Nature Medicine, vol. 15, no. 1, pp. 42-49, 2009.
22. J. H. Ylostalo, T. J. Bartosh, K. Coble, and D. J. Prockop, "Human mesenchymal stem/stromal cells cultured as spheroids are selfactivated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype, " StemCells, vol. 30, no. 10, pp. 2283-2296, 2012.
23. X.-X. Jiang, Y. Zhang, B. Liu et al. , "Humanmesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells, " Blood, vol. 105, no. 10, pp. 4120-4126, 2005.
24. A. J. Nauta, A. B. Kruisselbrink, E. Lurvink, R. Willemze, and W. E. Fibbe, "Mesenchymal stem cells inhibit generation and function of both CD34 +-derived and monocyte-derived dendritic cells, " Journal of Immunology, vol. 177, no. 4, pp. 2080-2087, 2006.
25. Y. P. Li, S. Paczesny, E. Lauret et al. , "Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway, " The Journal of Immunology, vol. 180, no. 3, pp. 1598-1608, 2008.
26. S. Huber, N. Gagliani, E. Esplugues et al. , "Th17 cells express interleukin-10 receptor and are controlled by Foxp3- and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner, " Immunity, vol. 34, no. 4, pp. 554-565, 2011.
27. A. Chaudhry, R. M. Samstein, P. Treuting et al. , "Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation, " Immunity, vol. 34, no. 4, pp. 566-578, 2011.
28. S. M. Anderton and S. Fillatreau, "Activated B cells in autoimmune diseases: the case for a regulatory role, " Nature Clinical Practice Rheumatology, vol. 4, no. 12, pp. 657-666, 2008.
29. K. Yanaba, J. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto, and T. F. Tedder, "A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses, " Immunity, vol. 28, no. 5, pp. 639-650, 2008.
30. R. Madan, F. Demircik, S. Surianarayanan et al. , "Nonredundant roles for B cell-derived IL-10 in immune counter-regulation, " Journal of Immunology, vol. 183, no. 4, pp. 2312-2320, 2009.
31. E. Zappia, S. Casazza, E. Pedemonte et al. , "Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy, " Blood, vol. 106, no. 5, pp. 1755-1761, 2005.
32. R. Tasso, C. Ilengo, R. Quarto, R. Cancedda, R. R. Caspi, and G. Pennesi, "Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis, " InvestigativeOphthalmology and Visual Science, vol. 53, no. 2, pp. 786-793, 2012.
33. X. Zhang, X. Ren, G. Li et al. , "Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity, " Investigative Ophthalmology and Visual Science, vol. 52, no. 6, pp. 3143-3152, 2011.
34. A. Peister, J. A. Mellad, B. L. Larson, B. M. Hall, L. F. Gibson, and D. J. Prockop, "Adult stem cells frombonemarrow(MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential, " Blood, vol. 103, no. 5, pp. 1662-1668, 2004.
35. J. Tolar, A. J. Nauta, M. J. Osborn et al. , "Sarcoma derived from cultured mesenchymal stem cells, " Stem Cells, vol. 25, no. 2, pp. 371-379, 2007.
36. D. J. Prockop and A. Keating, "Relearning the lessons of genomic stability of human cells during expansion in culture: implications for clinical research, " Stem Cells, vol. 30, no. 6, pp. 1051-1052, 2012.
37. G. Ren, J. Su, L. Zhang et al. , "Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression, " Stem Cells, vol. 27, no. 8, pp. 1954-1962, 2009.